Clinical Trial Update: SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating SGN-30 with combination chemotherapy in newly diagnosed anaplastic large cell lymphoma; the study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma

Drugs mentioned

• SGN-30 (brentuximab vedotin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Large Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2013-11-18